Publication | Closed Access

Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1–11 years

VaccinationVaccinologyInfectious Disease PreventionVaccine DevelopmentAntibody PersistenceViral HepatitisImmunodeficienciesImmunologyHepatitis BHepatitisImmunodominanceB VaccineCombined Hepatitis AHumoral ImmunityImmunotherapyMedicineVaccine Research